US FDA allows marketing of new device to help treat carbon monoxide poisoning


Your substances

None

This news contains references also to other Substances


The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.

CONTINUE READING ON www.fda.gov

                   

Related News

Loading...